HIKMA PHARMACEUTICALS USA INC has a total of 12 patent applications. It increased the IP activity by 300.0%. Its first patent ever was published in 2017. It filed its patents most often in United States, EPO (European Patent Office) and Canada. Its main competitors in its focus markets pharmaceuticals and medical technology are SANOVEL ILAC SANAYI VE TICARET AS, Nanjing tongrentang pharmaceutical co ltd and SONG XUGANG.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | Canada | 2 | |
#4 | China | 1 | |
#5 | Jordan | 1 | |
#6 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Medical purpose containers | |
#4 | Syringes |
# | Name | Total Patents |
---|---|---|
#1 | Potta Thrimoorthy | 10 |
#2 | Yan Ningxin | 10 |
#3 | Narayanan Eshwaran | 9 |
#4 | Chilampalli Chandeshwari | 9 |
#5 | Inavolu Rachana | 8 |
#6 | Bastian Craig | 8 |
#7 | Goskonda Venkat | 7 |
#8 | Amancha Kiran | 2 |
#9 | Goskonda Venkat R | 2 |
#10 | Chanana Gurmukh | 1 |
Publication | Filing date | Title |
---|---|---|
US2020237695A1 | Levothyroxine liquid formulations | |
US2020093818A1 | Liquid naloxone spray | |
EP3806827A1 | Epinephrine spray formulations | |
US2019216750A1 | Epinephrine spray formulations |